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Abstract
Background: DJ-1 forms part of the neuronal cellular defence mechanism against oxidative insults, due
to its ability to undergo self-oxidation. Oxidative stress has been implicated in the pathogenesis of central
nervous system damage in different neurodegenerative disorders including Alzheimer's disease and
Parkinson's disease (PD). Various mutations in the DJ-1 (PARK7) gene have been shown to cause the
autosomal recessive form of PD. In the present study South African PD patients were screened for
mutations in DJ-1 and we aimed to investigate the functional significance of a novel 16 bp deletion variant
identified in one patient.
Methods: The possible effect of the deletion on promoter activity was investigated using a Dual-
Luciferase Reporter assay. The DJ-1 5'-UTR region containing the sequence flanking the 16 bp deletion was
cloned into a pGL4.10-Basic luciferase-reporter vector and transfected into HEK293 and BE(2)-M17
neuroblastoma cells. Promoter activity under hydrogen peroxide-induced oxidative stress conditions was
also investigated. Computational (in silico) cis-regulatory analysis of DJ-1 promoter sequence was
performed using the transcription factor-binding site database, TRANSFAC via the PATCH™ and rVISTA
platforms.
Results: A novel 16 bp deletion variant (g.-6_+10del) was identified in DJ-1 which spans the transcription
start site and is situated 93 bp 3' from a Sp1 site. The deletion caused a reduction in luciferase activity of
approximately 47% in HEK293 cells and 60% in BE(2)-M17 cells compared to the wild-type (P < 0.0001),
indicating the importance of the 16 bp sequence in transcription regulation. The activity of both constructs
was up-regulated during oxidative stress. Bioinformatic analysis revealed putative binding sites for three
transcription factors AhR, ARNT, HIF-1 within the 16 bp sequence. The frequency of the g.-6_+10del
variant was determined to be 0.7% in South African PD patients (2 heterozygotes in 148 individuals).
Conclusion: This is the first report of a functional DJ-1 promoter variant, which has the potential to
influence transcript stability or translation efficiency. Further work is necessary to determine the extent
to which the g.-6_+10del variant affects the normal function of the DJ-1 promoter and whether this variant
confers a risk for PD.
Published: 13 October 2009
BMC Medical Genetics 2009, 10:105 doi:10.1186/1471-2350-10-105
Received: 18 February 2009
Accepted: 13 October 2009
This article is available from: http://www.biomedcentral.com/1471-2350/10/105
© 2009 Keyser et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 10
(page number not for citation purposes)
BMC Medical Genetics 2009, 10:105 http://www.biomedcentral.com/1471-2350/10/105Background
The DJ-1 gene (PARK7; OMIM 602533) was first
described about a decade ago [1] and encodes a 189
amino acid protein which belongs to the DJ-1/Thi/PfpI
protein super family [2,3]. It is ubiquitously expressed in
a variety of mammalian tissues including the brain, and
was initially described in association with oncogenesis
and male rat infertility [1,4,5]. Later it was shown to be
associated with autosomal recessive early-onset Parkin-
son's disease (PD) [3,6]. A few PD-causing mutations
have been identified including exon deletions, trunca-
tions, homozygous and heterozygous point mutations,
which predominantly result in loss of function [3,7]. The
expression of DJ-1 in the central nervous system (CNS) is
not restricted to specific anatomical or functional systems
and it is located in neuronal and glial cells within the sub-
stantia nigra [8,9].
DJ-1 is proposed to play a role in protecting neurons from
oxidative stress and protecting against mitochondrial
damage [10,11]. Oxidative stress can be defined as an
imbalance between reactive oxygen species (ROS) produc-
tion and the antioxidant capacity of a cell. Mitochondrial
dysfunction leading to increased ROS can cause damage
to various cellular components such as unsaturated lipids,
proteins, and nucleic acids, and this has been implicated
in various neurodegenerative disorders including Alzhe-
imer's disease, amyotrophic lateral sclerosis and PD [12].
Recent studies aimed at elucidating the function of DJ-1,
have found that it is able to undergo self oxidation in
order to eliminate hydrogen peroxide (H2O2) and, in so
doing, acts as a scavenger of ROS [11,13]. An increase in
susceptibility to oxidative stress of mammalian cells in
cases where DJ-1 was knocked down has been reported
[10,11]; cells were more susceptible to H2O2-induced cell
death due to DJ-1 knockdown and over-expression of
wild-type DJ-1 rescued the cells [14]. It has been reported
that DJ-1 is oxidatively damaged in the brains of PD
patients [15,16]. Studies showed that under oxidative
stress conditions, DJ-1 undergoes a shift in its isoelectric
point which leads to the accumulation of acidic isoforms
in PD frontal cortex tissue compared to age-matched con-
trols [15]. Up-regulation of DJ-1 as well as the intracellu-
lar redistribution of DJ-1 to the mitochondria under
oxidative stress conditions has been reported [10,17]. The
mitochondria have a central role in free radical generation
and it has been proposed that DJ-1 in the mitochondria
may have a role in preventing mitochondrial injury or
decreasing mitochondrial ROS production. Redistribu-
tion of DJ-1 to the mitochondria might be the neuronal
cellular defence mechanism against oxidative insults
[9,10,18].
DJ-1 is highly conserved across diverse species [19] and
there have been limited reports of sequence variants. An
18 bp insertion/deletion polymorphism (g.168_185del)
in DJ-1's promoter region has been reported to not confer
a risk for PD [20,21]. However, a homozygous duplica-
tion of this 18 bp sequence (g.168_185dup), as well as a
homozygous E163K mutation, have been identified in an
Italian family with a Parkinsonism-Dementia-Amyo-
trophic Lateral Sclerosis phenotype [22]. The duplication
and the E163K variants were not found in 1,400 and 500
control chromosomes, respectively. It has been reported
that the E163K mutation compromises the ability of DJ-1
to protect against oxidative stress induced by H2O2 [23]. It
is not known whether the phenotype in this family was
due to the g.168_185dup mutation or the E163K muta-
tion, or both.
In the present study, we investigated the functional signif-
icance of a novel 16 bp deletion which we identified in the
promoter region of DJ-1 in a PD patient by means of luci-
ferase functional expression studies. Unlike the 18 bp
insertion/deletion variant, the 16 bp deletion occurs in a
transcriptionally important region of the gene as it spans
the transcription start site.
Methods
Study participants
The study protocol was approved by the Committee for
Human Research at the University of Stellenbosch, South
Africa (Protocol number 2002/C059). In the initial part of
the study 30 unrelated South African PD patients were
recruited with informed written consent from the Move-
ment Disorders clinic at Tygerberg Hospital in South
Africa. The patients were examined by a movement disor-
der specialist (JC) and all met the UK Parkinson's Disease
Society Brain Bank Research criteria for diagnosis of PD
[24]. Inclusion criteria for recruitment of patients were
early onset and/or positive family history of PD. The aver-
age age at onset (AAO) of the study group was 43 years
and ranged from 17 years to 77 years. The percentage of
males in our study group was 66%. Once the 16 bp dele-
tion variant was detected, the frequency of the variant was
determined in a total of 148 unrelated South African PD
patients (average AAO = 52 years). Blood samples for 62
controls representing the mixed ancestry ethnic group
were recruited from unrelated blood donors at the South
African Western Province Blood Transfusion Service
blood collection clinics. The controls had been 'de-identi-
fied' and had not been clinically assessed for signs of PD.
Genetic analysis
The single-strand conformational polymorphism analysis
method was used to screen the 30 PD patients for genetic
variations in all 7 exons and the 5' UTR of DJ-1. Samples
exhibiting altered mobilities on mildly-denaturing poly-
acrylamide gels (containing 5% glycerol and 15% urea)
were sequenced in order to characterize the sequence var-Page 2 of 10
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Terminator Sequence Ready Reaction kit version 3.1
(Applied Biosystems, Foster City, USA) and analysis was
conducted on a 3130 xl Genetic Analyser (Applied Biosys-
tems).
Construction of luciferase vectors
Functional analysis of a novel 16 bp deletion identified in
the 5'-UTR was performed using a Dual-Luciferase
Reporter Assay System http://www.promega.com/pGL4.
In this assay, the activities of the firefly (Photinus pyralis;
the experimental reporter gene) and the Renilla (Renilla
reniformis or sea pansy; the internal control gene) luci-
ferases are measured sequentially from a single sample.
The firefly luciferase gene is present on the promoterless
pGL4.10 [luc2] vector and the Renilla luciferase gene is on
the phRL-SV40 vector. The pGL4 luciferase reporter vector
was used in this study because it has been codon opti-
mized for more efficient expression in mammalian cells.
The reporter gene and the vector backbone have been
engineered to reduce the number of consensus transcrip-
tion factor binding sites, which leads to reduced back-
ground luminescence and the risk of anomalous
transcription. In this experiment the pGL4.10 [luc2] and
phRL-SV40 vectors are used to co-transfect mammalian
cells and due to their distinct evolutionary origins the
activity of two luciferases can be distinguished since they
have different enzyme structures and substrate require-
ments.
The promoter region of DJ-1 containing sequence span-
ning the 16 bp deletion was PCR amplified from genomic
DNA from the individual harbouring the deletion variant
using primers containing restriction sites for cloning.
Primers were designed to PCR amplify a fragment from
position 1 to 2119 bp (GenBank accession number
AB045294). It was decided to include the entire 5'UTR
sequence in the luciferase assay to ensure that all sites
important for transcription initiation and regulation,
especially under hydrogen peroxide-induced oxidative
stress conditions, were present. A similar sized construct
had previously been used successfully to assess promoter
function of DJ-1 in a study done by Taira et al., 2001 [19].
Two constructs were generated; wild-type [pDJ-1(wt)Luc]
and a 16 bp deletion variant [pDJ-1(del)Luc]. Primer
sequences used were: forward 5'-ATC GTA TCG CTC GAG
GGA TCC TTC TAA GCT CAT TC-3' and reverse 5'-CAG
AGC TCT TTT GGA AGC AAG CTT CGATACGAT-3'. PCR
reactions were performed in a 2720 Thermal Cycler
(Applied Biosystems). The 50 μl reactions contained 200
ng template DNA (wild-type or deletion), 20 pmoles of
each primer, 75 μM dNTPs (Promega), 1.5 mM MgCl2, 1×
NH4 buffer (Bioline), 5% DMSO and 0.5 units of BIO-
TAQ DNA polymerase (Bioline). The PCR cycling param-
eters entailed an initial denaturation step at 95°C for 7
min, followed by 30 cycles of denaturation at 95°C for 30
sec, annealing at 50°C for 30 sec and extension at 72°C
for 2 min, and a final extension step at 72°C for 10 min.
The 2,151-kb sized PCR products (either wild-type
sequence or 16 bp deletion sequence), as well as pGL4.10
[luc2] were digested with XhoI and HindIII (Fermentas)
and purified (Wizard SV Gel and PCR Clean-up system,
Promega). Vector arms were dephosphorylated (CIP,
Promega) and ligated overnight to the digested PCR frag-
ments. The pDJ-1(wt)Luc and pDJ-1(del)Luc constructs
were subcloned into E. coli DH5α cells and single colo-
nies were miniprepped (GeneJET plasmid miniprep kit,
Promega). Insertion of the DJ-1 promoter sequence in-
frame with the firefly luciferase gene in the pGL4.10 [luc2]
vector was verified by direct sequencing using the BigDye
Terminator Sequence Ready Reaction kit version 3.1
(Applied Biosystems) and analyzed on a 3130 xl Genetic
Analyzer (Applied Biosystems).
PCR-restriction fragment length polymorphism (RFLP) 
analysis
PCR-restriction fragment length polymorphism (RFLP)
analysis was used to screen 148 PD patients and 62 con-
trol samples for the presence of the 16 bp deletion variant.
The control samples were of South African mixed ancestry
descent which can be defined as an admixture of indige-
nous African populations and immigrants from mainly
Western Europe, Madagascar, Malaysia and India. The fol-
lowing PCR primers were designed which span the 16 bp
deletion: forward 5'-ACC CAG GGC TGT CCA GCT A-3'
and reverse 5'-GTC CAG CAC AGG GAC ACC-3' and pro-
duced a PCR product of 321 bp and 305 bp for the wild
type and deletion alleles, respectively. A total of 8 μl of the
PCR product was digested overnight at 37°C with 5 units
of KpnI (Promega) in a final volume of 20 μl. Thereafter,
the digested products were electrophoresed on 12% poly-
acrylamide gels and the bands visualized by silver stain-
ing. Following the KpnI digest, the samples could be
genotyped since the wild type allele produced two frag-
ments of 129 bp and 192 bp whereas the 16 bp deletion
allele produced two fragments of 129 bp and 176 bp.
Cell culture
Human embryonic kidney cells (HEK293) (Highveld Bio-
logical, Pty, Ltd, South Africa) and human dopaminergic
neuroblastoma BE(2)-M17 cells (American Type Culture
Collection, USA) were cultured separately under sterile
conditions in Dulbecco-modified Eagle medium (LONZA
BioWhittaker®) supplemented with 10% fetal calf serum,
penicillin (100 units/ml), and streptomycin (100 μg/ml)
in 5% CO2 humidified atmosphere at 37°C.
Plasmid transfection and luciferase assay
Cultured HEK293 and M17 cells were plated 24 hrs prior
to transfection into 6-well culture dishes at 80-90% con-
fluence and maintained at an atmosphere of 5% CO2 atPage 3 of 10
(page number not for citation purposes)
BMC Medical Genetics 2009, 10:105 http://www.biomedcentral.com/1471-2350/10/10537°C. For transfections, 1 μg of DNA was added with 3 μl
Fugene (Roche Biochemicals) and serum-free media to a
total volume of 100 μl (DNA/Fugene/media complex).
The complex was then added to the cells in the culture
dishes in a drop-wise manner. The pDJ-1(wt)Luc and pDJ-
1(del)Luc constructs were co-transfected with phRL-SV40,
an internal control vector containing the Renilla luciferase
gene (Promega), in a ratio of 50:1 (pGL4 versus phRL-
SV40), in order to control for transfection efficiency.
Twenty four hours after transfection, the cells were
exposed to H2O2 (0-75 μM), in order to produce ROS for-
mation. Forty eight hours after transfection, the cells were
gently rinsed with phosphate buffered saline and har-
vested with Passive Lysis Buffer (Promega). The Dual-luci-
ferase® Reporter Assay System (Promega) was used to
measure luciferase activity. Twenty microliters of cell
lysate were added to 100 μl of luciferase assay reagent II
(Promega) and the firefly luminescence was read using a
Modulus 96 Luminometer. Next, 100 μl of Stop&Glo® rea-
gent (Promega) was added to the lysates and renilla lumi-
nescence was read. Luminescence values of firefly were
normalized with renilla for each construct within an
experiment. The luciferase assay was repeated in four
independent experiments for each cell type and the lumi-
nescence readings were read in triplicate.
Clonogenic survival assay
A clonogenic survival assay was conducted in order to
determine the appropriate concentration of H2O2 to use
in the luciferase assay. The cultured HEK293 and M17
cells were plated in appropriate dilutions (1000-2000
cells/well) into 6-well plates, and incubated for 48 hrs.
The cells were then exposed to varying concentrations of
H2O2 (0, 25, 50 and 75 μM) and incubated for approxi-
mately one week. Thereafter, the cells were fixed and
stained with 0.2% crystal violet (Merck) overnight for vis-
ual colony count. The IC50 values (concentration of H2O2
required to inhibit colony formation by 50%) were deter-
mined for both cell lines.
Bioinformatics
Computational (in silico) cis-regulatory analysis of DJ-1
promoter sequence was performed using the transcription
factor-binding site database, TRANSFAC via the PATCH™
platform http://www.gene-regulation.com. For PATCH™
analysis, the primary parameter settings were set as: Mini-
mum Length of Sites at 4 and Lower Score Boundary at
85%. The multi-species conserved sequence analyses were
performed using the rVISTA (regulatory VISTA) platform
http://genome.lbl.gov/vista/index.shtml at default cut-off
criteria: ≥ 70% identity over a contiguous paired sequence
length ≥ 100 bp. rVISTA combines searching the major
transcription factor binding site database TRANSFAC with
a comparative sequence analysis. DJ-1 promoter
sequences (2 kb upstream and 5'-UTR) from human
(Ensembl Gene ID: ENSG00000116288; H. sapiens),
chimpanzee (ENSPTRG00000000102, P. troglodytes),
orangutan (ENSPPYG00000001925, P. pygmaeus),
macaque (ENSMMUG00000019671, M. mulatta), tree
shrew (ENSTBEG00000009474, T. belangeri), horse
(ENSECAG00000017251, E. caballus), dog
(ENSCAFG00000019674, C. familiaris), cow
(ENSBTAG00000020518, B. taurus), mouse
(ENSMUSG00000028964, M. musculus) and rat
(ENSRNOG00000018289, R. norvegicus) were retrieved
from the Ensembl Genome Browser (archive version at
http://jul2008.archive.ensembl.org/index.html).
Statistical analysis
The open-source programming environment R (freely
available from http://www.r-project.org) was used for the
statistical analysis. A linear mixed-effects model was cre-
ated to analyse the data. All the relative light units (RLU)
values were first log-transformed towards symmetry, and
then modelled as a function of the factors including cell
line (HEK293 or M17), Type (WT or deletion) and H2O2
concentration (0, 25, 50 or 75 μM) as fixed effects. We
also included interactions between Type and cell line, as
well as between Type and H2O2 concentration, both of
which were independently significant after adjusting for
all the other effects. As the individual experiments yielded
RLU values that were dissimilar, each experiment were
included in the model as a random effect. All the results
reported here come from the same model, and were there-
fore adjusted for all the other factors in the model, as well
as the random effect of individual experiments.
Results
During mutation screening of South African PD patients a
novel 16 bp deletion in the promoter region of DJ-1 was
identified. The frequency of this deletion (g.-6_+10del)
was estimated to be 0.7% (95% confidence interval 0.2%
to 2.4%), based on 2 heterozygotes in 148 South African
PD patients screened. Both patients were sporadic individ-
uals of South African mixed ancestry. One of the patients
presented with PD at age 38 years. He had displayed early
onset of prominent autonomic dysfunction and halluci-
nations (with psychosis) and had died at the age of 47
years. The other patient had an age at onset of 56 years
and also has a history of psychotic episodes. Furthermore,
the g.-6_+10del variant was observed in a homozygous
state in one of 62 mixed ancestry control individuals
screened (1.6%). This individual was aged 34 years and
had not been clinically assessed for signs of PD.
The 16 bp deletion spans the transcription start site of DJ-
1 which had previously been identified by Taira et al. [19]
using the method of 'CAP site hunting'. This variant is sit-
uated 93 bp downstream of a Sp1 site, which has been
shown to be necessary for DJ-1 transcription [19], and 157Page 4 of 10
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phism (Figure 1). We hypothesized that this deletion
would disrupt transcription of DJ-1 and this hypothesis
was tested using a luciferase reporter assay. DJ-1 has pre-
viously been shown to be expressed in the HEK293 cell
line [19] and these cells were therefore used in the initial
experiments.
To determine the in vitro effect of the deletion variant on
DJ-1 promoter activity, two different constructs (wild-type
and deletion variant) were generated. The promoter
region of DJ-1 containing the sequence spanning the 16
bp deletion, as well as transcriptionally important sites
such as the transcription start site and Sp1 site, was linked
to the firefly luciferase gene and the luciferase activity was
measured in RLU. Both constructs contained the 18 bp of
the polymorphic variant (g.168_185del). The results
obtained are therefore likely to be due only to the pres-
ence or absence of the 16 bp sequence.
The linear mixed-effects model for log(RLU) values,
showed a significant interaction between construct type
and H202 concentration (p = 0.0010) and also between
construct type and cell line (p = 0.0119). All three factors:
cell line, construct type and H202 concentration, had
highly significant effects (p < 0.0001) on log(RLU) after
adjusting for the interactions and experiments. All the P-
values presented in the present study come from this
model and they are therefore adjusted for the differences
between the individual experiments as well as all the other
factors in the model [the cell line (HEK293 or M17), con-
struct type (WT or deletion) and H2O2 concentration (0,
25, 50 or 75 μM) as well as the interactions between Type
and cell line, and between Type and H2O2 concentration].
We compared the geometric means (the mean of the logs,
which is then anti-logged) of the observed RLU values
obtained for each combination of the M17 cells, the con-
struct type and the H2O2 concentration to the predicted
means generated by the model (results not shown). These
results indicated that the model fitted the data well and
we therefore have confidence in our results.
The wild-type construct produced consistently higher luci-
ferase activity compared to the activity of a promoterless
vector, which indicated that the insert contained a func-
tional promoter (results not shown). Figure 2 shows the
distribution of the normalized RLU values obtained for
the wild-type and deletion variant in both cell lines. There
was a significant difference between the wild-type and the
deletion variant in the HEK293 cell line, after adjusting
for experiments and all other factors. The deletion caused
a reduction in luciferase activity of approximately 47%
compared to the wild-type, indicating that the 16 bp
sequence is probably important for the transcriptional
regulation of DJ-1 (Figure 2A). Conducting the assay in
M17 neuroblastoma cells (Figure 2B) produced similar
results with an even larger reduction of 60% in luciferase
activity observed for the deletion compared to the wild-
type. From the box plots of the data, it was noted that for
both cell lines, approximately 75% of the RLU values of
the deletion variant were less than the lower 25% quartile
of the RLU values for the wild-type (Figure 2), which illus-
trates the significant difference in the RLU values between
the two constructs.
H2O2 treatment of the M17 neuroblastoma cells
The effect of the deletion variant on DJ-1 promoter activ-
ity under H2O2-induced oxidative stress conditions was
investigated using M17 neuroblastoma cells. DJ-1 is a
scavenger of ROS and is proposed to play a role in protect-
ing neurons from oxidative stress. A clonogenic survival
assay was first performed to assess the concentration of
H2O2 to use for these experiments. The IC50 values (con-
centration of H2O2 required to inhibit colony formation
by 50%) were shown to be 50 μM for both cell lines
(results not shown). The H2O2 concentration of 75 μM
had the highest cytotoxic effect on both cell lines.
Under H2O2-induced oxidative stress conditions, the dele-
tion variant again exhibited significantly reduced pro-
moter activity compared to the wild-type for the untreated
as well as at all three concentrations of H2O2 (Figure 3).
The promoter activity of both the wild-type and deletion
was moderately upregulated during these oxidative stress
conditions with increasing concentrations of H2O2. How-
ever, this trend was not observed at the highest H2O2 con-
centration of 75 μM, possibly because of increased cell
death at this dosage. Although both the wild-type and
deletion exhibited increased promoter activity with
increasing concentrations of H2O2, the promoter activity
for the deletion variant was always lower than that of the
wild-type. In a post-hoc analysis with H2O2 as dichoto-
mous [treated (all concentrations > 0) versus untreated]
we found a highly significant difference (p < 0.0001) in
promoter activity between untreated cells and H2O2
treated cells (after adjusting for all other factors in model,
namely the construct type, the cell line and the H2O2 con-
centrations (0, 25, 50 or 75 μM) and the interactions
between type and each of the other two factors).
Computational cis-regulatory analysis of DJ-1
Interestingly, the 16 bp deletion sequence contains three
perfect 5'-GCGT-3' and one imperfect repeat (5'-GCTG-
3'). The functionality of this particular motif is currently
not known. Analysis of the 16 bp deletion sequence
(using the TRANSFAC database via PATCH and rVISTA)
revealed the over-representation of three putative cis-
motifs that correlate to the transcription factors Aryl
hydrocarbon receptor (AhR; TRANSFAC Acc. Nr. T00018),
Ahr nuclear translocator (ARNT; T01797) and HypoxiaPage 5 of 10
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Nucleotide sequence of the promoter region of the human DJ-1 gene (GenBank Accession number AB045294) showing the positions of significant si esFigure 1
Nucleotide sequence of the promoter region of the human DJ-1 gene (GenBank Accession number AB045294) 
showing the positions of significant sites. The +1 indicates the transcription start site. The position of the 16 bp deletion 
sequence is indicated by a single underline and the Sp1 site by a double underline. The position of the 18 bp insertion/deletion 
polymorphism (g.168_185del) is indicated in blue font and the positions of the primers used to generate the luciferase con-
structs are shown in bold green font. The positions of putative cis-motifs (AhR/ARNT and HIF-1) present in the 16 bp deletion 
sequence are indicated by arrows.
BMC Medical Genetics 2009, 10:105 http://www.biomedcentral.com/1471-2350/10/105induced factor 1 (HIF-1; T01609) within the 16 bp
sequence (Figure 1). The core binding sequence for AhR
and ARNT is 5'-CACGC-3' and for HIF-1 is 5'-RCGTG-3'.
These transcriptional regulators control a variety of devel-
opmental and physiological events including metabolism
of toxins and responses to hypoxia [25,26], and share reg-
ulatory cross-talk with many other transcription factors.
When the 16 bp sequence is deleted a transcription factor
site is created. In silico promoter analysis revealed that the
sequence in the (-) strand (GCGCGTTC) of the 16 bp
deleted region conforms to a novel cis-motif that puta-
tively correlated to cis/trans interaction with the E2F-class
of transcription factors.
Multi-species comparative analysis using rVISTA, [27],
showed regions of ≥ 70% conserved identity (over contig-
uous sequence length: 100 bp) of the human DJ-1 pro-
moter region to chimpanzee (1754 bp), orangutan (1347
bp), macaque (1239 bp), tree shrew (233 bp) and horse
(248 bp). All the other species investigated including rat
and mouse showed ≤ 70% conservation (Figure 4).
Discussion
In the present study we report a novel 16 bp deletion (g.-
6_+10del) in the promoter region of DJ-1. The deletion
was shown to span the transcription start site, according
to Taira et al. 2001 [19] and is situated 93 bp downstream
of a Sp1 transcription regulatory sequence which is essen-
tial for DJ-1 promoter activity. In addition, the g.-
6_+10del variant is located 157 bp upstream from a
known 18 bp duplication mutation (g.168_185dup). The
duplication mutation has previously been reported to co-
segregate, together with a homozygous E163K mutation,
with early-onset Parkinsonism-Dementia-Amyotrophic
Lateral Sclerosis in an Italian family [22]. Due to its loca-
tion within the DJ-1 promoter, we hypothesised that the
16 bp deletion variant might influence the level of DJ-1
expression, the transcript stability or the translation effi-
ciency.
Functional expression studies using the dual-luciferase
reporter system found that the g.-6_+10del variant signif-
icantly reduced DJ-1 promoter activity in both HEK293
and neuroblastoma M17 cells, with the M17 cells exhibit-
The DJ-1 16 bp deletion variant exhibited significantly reduced transcription levels compared to the wild-type (P < 0.0001) in two different cell linesFigure 2
The DJ-1 16 bp deletion variant exhibited significantly reduced transcription levels compared to the wild-type 
(P < 0.0001) in two different cell lines. Box plots of dual-luciferase assays of the wild-type and deletion variant using (A) 
HEK293 cells and (B) neuroblastoma M17 cells. They include median (horizontal line within box), inter-quartile interval i.e. 25th 
to 75th percentile (box) and the range of variation (whiskers). The 2 kb promoter fragments (containing either wild-type 
sequence or the deletion) were linked to the luciferase gene and the constructs were transfected into two mammalian cell 
lines. For each experiment, firefly luciferase activity was divided by renilla activity to normalize for transfection efficiency. Data 
are representative of four transfection experiments (triplicate points obtained over four independent experiments). WT: wild-
type; D: deletion variant; RLU: relative light units.Page 7 of 10
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ble importance of the 16 bp sequence in transcriptional
regulation of DJ-1. Recent studies aiming to elucidate the
function of DJ-1, have identified it as a scavenger of ROS
due to its ability to undergo self oxidation in order to
eliminate H2O2 [11]. It was therefore decided to assess the
effect of the deletion variant on DJ-1 promoter activity
under H2O2-induced oxidative stress conditions using the
neuroblastoma M17 cell line. In the present study it was
shown that cells placed under oxidative stress conditions
showed a dose-dependent moderate up-regulation in
both wild-type and deletion variant's promoter activities
with the deletion variant retaining its lower RLU values
compared to the wild-type.
Furthermore, bioinformatic analysis identified binding
sites for the transcription factors; Aryl hydrocarbon recep-
tor (AhR), Ahr nuclear translocator (ARNT) and Hypoxia
induced factor 1 (HIF-1) within the 16 bp deletion
sequence. AhR and ARNT are known to dimerize to form
an active transcription factor complex that binds defined
DNA sequences, the xenobiotic-responsive element
(XRE), with high affinity causing an increase in transcrip-
tion of AhR-regulated genes [26,28,29]. The AhR/ARNT
complex up-regulates cytochrome P450 enzymes that play
diverse roles in metabolism of endogenous substances,
environmental chemicals and various drugs [29]. AhR
functions as the prime transcription factor and ARNT as a
DNA binding partner. Transcriptional up-regulation dur-
ing hypoxia is mediated principally by HIF-1 (a dimer of
HIF-1α and ARNT). The anticancer property of curcumin
has been shown to be due to inactivation of HIF-1 by deg-
radation of ARNT via oxidation and ubiquitination proc-
esses [30]. It was also shown that curcumin induces
proteasomal degradations of both AhR and ARNT and this
is mediated by oxidative stress [31]. It is possible that the
AhR/ARNT or HIF-1 complexes may interact with DJ-1's
promoter thereby regulating its transcription and there-
fore indirectly influencing the transcription of various
genes associated with oxidative stress, apoptosis and neu-
rotoxicity that are regulated by DJ-1 [32].
Further analysis found that when the 16 bp sequence is
deleted, a binding site for the E2F-class of transcription
factors is created. E2F has been shown to induce transcrip-
tion of pro-apoptotic proteins and repression of E2F-
responsive genes is required for neuronal survival [33].
Recent studies found that the pRb/E2F cell-cycle pathway
is activated in dopaminergic neurons in PD patients, as
well as in a PD mouse model [34].
DJ-1 is highly conserved at both the nucleotide and amino
acid level, possibly due its important role in protection
against oxidative stress. Mouse and human DJ-1 is 83%
and 90% identical at the DNA and protein level, respec-
tively [19]. Similarly, the conservation between porcine
and human DJ-1 is 96% at the protein level [35]. There
have been no reports however on the level of conservation
of DJ-1's 5'-UTR sequence. We showed through multi-spe-
cies comparative analysis that the promoter region of DJ-
1 is highly conserved, as expected, between man and other
primates as well as to a few other species. More impor-
tantly, the 16 bp deletion sequence is present in a highly
conserved promoter region (Figure 4) indicating the pos-
sible significance of this sequence in higher order mam-
mals and thus an evolutionarily retained functionality.
It would be interesting to determine the prevalence of the
g.-6_+10del variant in other populations and to establish
whether it plays a role in susceptibility to neurodegenera-
tive diseases such as PD. Further studies are necessary to
determine whether endogenous levels of DJ-1 are affected
by the 16 bp deletion and whether an alternative tran-
scriptional start site is present. In addition, introducing
point mutations into the predicted transcription factor
binding sites within the 16 bp sequence to determine the
effect on DJ-1's transcription and the cell's response to
oxidative stress would be of interest.
Conclusion
We report a novel sequence variant in the highly con-
served DJ-1 gene. Functional expression studies found
that this variant significantly reduced DJ-1 promoter activ-
H2O2 dose-dependent up-regulation of DJ-1 promoter activ-ityFigure 3
H2O2 dose-dependent up-regulation of DJ-1 pro-
moter activity. Box plots of the dual-luciferase assay of the 
16 bp DJ-1 deletion variant using the neuroblastoma M17 cell 
line and exposure to different concentrations of H2O2 (0, 25, 
50 and 75 μM). *: geometric means; WT: wild-type; D: dele-
tion variant; 0, 25, 50, 75: H2O2 concentrations.Page 8 of 10
(page number not for citation purposes)
BMC Medical Genetics 2009, 10:105 http://www.biomedcentral.com/1471-2350/10/105ity in two separate mammalian cell lines, which indicates
the possible importance of the 16 bp sequence in tran-
scriptional regulation of DJ-1. In addition, the activity of
three transcription factors with recognition sites within
the deletion sequence might be influenced by the g.-
6_+10del variant.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RJK performed the laboratory work and drafted the man-
uscript. LvdM performed the statistical analysis. MV con-
ducted the bioinformatic analysis. LW and JC critically
reviewed the manuscript. CK assisted with laboratory
work and critically reviewed the manuscript. SB partici-
pated in the conception and design, and helped to draft
the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
We thank the study participants and Ms D Lombard for collection of blood 
samples. Ms L Korkie, Mr R Vogt, Dr. M Zaahl and Dr. J Riedemann are 
thanked for technical assistance with tissue culture, luciferase assays and 
clonogenic survival assays. This work was supported by the South African 
Medical Research Council, the Harry and Doris Crossley Foundation and 
the University of Stellenbosch, South Africa.
References
1. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM,
Ariga H: DJ-1, a novel oncogene which transforms mouse
NIH3T3 cells in cooperation with ras.  Biochem Biophys Res Com-
mun 1997, 231(2):509-513.
Comparative multi-species analysis using rVISTA of the DJ-1 promoter region of approximately 2000 bp + 5'-UTRFigure 4
Comparative multi-species analysis using rVISTA of the DJ-1 promoter region of approximately 2000 bp + 5'-
UTR. Conserved percentage identity is indicated with cut-off criteria: ≥ 70% identity over ≥ 100 bp are indicated in orange and 
the white regions represent either no alignment or ≤ 70% sequence identity over 100 bp contiguous sequence length. The 16 
bp deletion sequence is represented by an arrow on a dashed line and is found in a region sharing highly conserved identity 
between species.Page 9 of 10
(page number not for citation purposes)
BMC Medical Genetics 2009, 10:105 http://www.biomedcentral.com/1471-2350/10/105Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
2. Huai Q, Sun Y, Wang H, Chin LS, Li L, Robinson H, Ke H: Crystal
structure of DJ-1/RS and implication on familial Parkinson's
disease.  FEBS Lett 2003, 549(1-3):171-175.
3. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E,
Dekker MCJ, Squitieri F, Ibanez P, Joosse M, et al.: Mutations in the
DJ-1 gene associated with autosomal recessive early-onset
Parkinsonism.  Science 2003, 299(5604):256-259.
4. Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, DeLuca C,
Liepa J, Zhou L, Snow B, Binari RC, Manoukian AS, Bray MR, Liu FF,
Tsao MS, Mak TW: DJ-1, a novel regulator of the tumor sup-
pressor PTEN.  Cancer Cell 2005, 7(3):263-273.
5. Wagenfeld A, Yeung CH, Strupat K, Cooper TG: Shedding of a rat
epididymal sperm protein associated with infertility induced
by ornidazole and alpha-chlorohydrin.  Biol Reprod 1998,
58(5):1257-1265.
6. Abou-Sleiman PM, Healy DG, Wood N: Causes of Parkinson's dis-
ease: genetics of DJ-1.  Cell Tissue Res 2004, 318:185-188.
7. Bonifati V, Oostra BA, Heutink P: Linking DJ-1 to neurodegener-
ation offers novel insights for understanding the pathogene-
sis of Parkinson's disease.  J Mol Med 2004, 82:163-174.
8. Bader V, Ran Zhu X, Lübbert H, Stichel CC: Expression of DJ-1 in
the adult mouse CNS.  Brain Res 2005, 1041(1):102-111.
9. Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, Marupudi NI, Torp
R, Torgner IA, Ottersen OP, Dawson TM, et al.: Mitochondrial
localization of the Parkinson's disease related protein DJ-1:
implications for pathogenesis.  Hum Mol Genet 2005,
14:2063-2073.
10. Lev N, Ickowicz D, Melamed E, Offen D: Oxidative insults induce
DJ-1 upregulation and redistribution: Implications for neuro-
protection.  Neurotoxicology 2008, 29(3):397-405.
11. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H: DJ-1
has a role in antioxidative stress to prevent cell death.  EMBO
Rep 2004, 5(2):213-218.
12. Lin MT, Beal MF: Mitochondrial dysfunction and oxidative
stress in neurodegenerative diseases.  Nature 2006,
443(7113):787-795.
13. Kinumi T, Kimata J, Taira T, Ariga H, Niki E: Cysteine-106 of DJ-1
is the most sensitive cysteine residue to hydrogen peroxide-
mediated oxidation in vivo in human umbilical vein endothe-
lial cells.  Biochem Biophys Res Commun 2004, 317(3):722-728.
14. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizusawa H:
Down regulation of DJ-1 enhances cell death by oxidative
stress, ER stress, and proteasome inhibition.  Biochem Biophys
Res Commun 2003, 312(4):1342-1348.
15. Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, Bostwick
DE, Gearing M, Levey AI, Chin LS, Li L, et al.: Oxidative damage of
DJ-1 is linked to sporadic Parkinson and Alzheimer diseases.
J Biol Chem 2006, 281(16):10816-10824.
16. Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM,
Hope AD, Pittman AM, Lashley T, Canet-Aviles R, Miller DW, et al.:
The expression of DJ-1 (PARK7) in normal human CNS and
idiopathic Parkinson's disease.  Brain 2004, 127:420-430.
17. Lev N, Ickowicz D, Barhum Y, Lev S, Melamed E, Offen D: DJ-1 pro-
tects against dopamine toxicity.  J Neural Transm 2009,
116(2):151-160.
18. Canet-Avilés RM, Wilson MA, Miller DW, Ahmad R, McLendon C,
Bandyopadhyay S, Baptista MJ, Ringe D, Petsko GA, Cookson MR:
The Parkinson's disease protein DJ-1 is neuroprotective due
to cysteine-sulfinic acid-driven mitochondrial localization.
Proc Natl Acad Sci USA 2004, 101(24):9103-9108.
19. Taira T, Takahashi K, Kitagawa R, Iguchi-Ariga SM, Ariga H: Molecu-
lar cloning of human and mouse DJ-1 genes and identifica-
tion of Sp1-dependent activation of the human DJ-1
promoter.  Gene 2001, 263(1-2):285-292.
20. Eerola J, Hernandez D, Launes J, Hellstrom O, Hague S, Gulick C,
Johnson J, Peuralinna T, Hardy J, Tienari PJ, et al.: Assessment of a
DJ-1 (PARK7) polymorphism in Finnish PD.  Neurology 2003,
61:1000-1002.
21. Morris CM, O'Brien KK, Gibson AM, Hardy JA, Singleton AB: Poly-
morphism in the human DJ-1 gene is not associated with spo-
radic dementia with Lewy bodies or Parkinson's disease.
Neurosci Lett 2003, 352(2):151-153.
22. Annesi G, Savettieri G, Pugliese P, D'Amelio M, Tarantino P, Ragonese
P, La Bella V, Piccoli T, Civitelli D, Annesi F, et al.: DJ-1 mutations
and parkinsonism-dementia-amyotrophic lateral sclerosis
complex.  Ann Neurol 2005, 58:803-807.
23. Ramsey CP, Giasson BI: The E163K DJ-1 mutant shows specific
antioxidant deficiency.  Brain Res 2008:1-11.
24. Gibb WR, Lees AJ: A comparison of clinical and pathological
features of young-and old-onset Parkinson's disease.  Neurol-
ogy 1988, 38(9):1402-1406.
25. Wilson CL, Safe S: Mechanisms of ligand-induced aryl hydro-
carbon receptor-mediated biochemical and toxic responses.
Toxicol Pathol 1998, 26(5):657-671.
26. Pocar P, Fischer B, Klonisch T, Hombach-Klonisch S: Molecular
interactions of the aryl hydrocarbon receptor and its biolog-
ical and toxicological relevance for reproduction.  Reproduction
2005, 129:379-389.
27. Loots GG, Ovcharenko I, Pachter L, Dubchak I, Rubin EM: rVista for
comparative sequence-based discovery of functional tran-
scription factor binding sites.  Genome Res 2002, 12(5):832-839.
28. Denison MS, Fisher JM, Whitlock JP Jr: The DNA recognition site
for the dioxin-Ah receptor complex. Nucleotide sequence
and functional analysis.  J Biol Chem 1988, 263(33):17221-17224.
29. Rivera SP, Wang F, Saarikoski ST, Taylor RT, Chapman B, Zhang R,
Hankinson O: A novel promoter element containing multiple
overlapping xenobiotic and hypoxia response elements
mediates induction of cytochrome P4502S1 by both dioxin
and hypoxia.  J Biol Chem 2007, 282(15):10881-10893.
30. Choi H, Chun YS, Kim SW, Kim MS, Park JW: Curcumin inhibits
hypoxia-inducible factor-1 by degrading aryl hydrocarbon
receptor nuclear translocator: a mechanism of tumor
growth inhibition.  Mol Pharmacol 2006, 70(5):1664-1671.
31. Choi H, Chun YS, Shin YJ, Ye SK, Kim MS, Park JW: Curcumin
attenuates cytochrome P450 induction in response to
2,3,7,8-tetrachlorodibenzo-p-dioxin by ROS-dependently
degrading AhR and ARNT.  Cancer Sci 2008, 99(12):2518-2524.
32. da Costa CA: DJ-1: a newcomer in Parkinson's disease pathol-
ogy.  Curr Mol Med 2007, 7(7):650-657.
33. Liu DX, Greene LA: Regulation of neuronal survival and death
by E2F-dependent gene repression and derepression.  Neuron
2001, 32(3):425-438.
34. Höglinger GU, Breunig JJ, Depboylu C, Rouaux C, Michel PP, Alvarez-
Fischer D, Boutillier AL, Degregori J, Oertel WH, Rakic P, et al.: The
pRb/E2F cell-cycle pathway mediates cell death in Parkin-
son's disease.  Proc Natl Acad Sci 2007, 104(9):3585-3590.
35. Larsen K, Madsen LB, Høj A, Bendixen C: Porcine DJ-1: cloning of
PARK7 cDNA, sequence comparison, expression analysis
and chromosomal localization.  Cytogenet Genome Res 2007,
116(1-2):93-09.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2350/10/105/pre
pubPage 10 of 10
(page number not for citation purposes)
